Greenwich LifeSciences, Inc. - COM (GLSI)

Historical Holders from Q3 2020 to Q3 2025

Type / Class
Equity / COM
Symbol
GLSI on Nasdaq
Price per share
$9.95
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1,214,197
Holdings value
$12,081,502
% of all portfolios
0%
Share change
-104,975
Value change
-$993,068
Average buys %
+0%
Average sells %
-0%
Number of holders
51
Price from insider filings
$21.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, Greenwich LifeSciences, Inc. - COM (GLSI) has 51 institutional shareholders filing 13F forms. They hold 1,214,197 shares .

Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,214,197 $12,081,502 -$993,068 $9.95 51
2025 Q2 1,231,674 $11,172,252 +$1,418,411 $9.07 51
2025 Q1 1,161,900 $11,084,861 -$205,963 $9.54 45
2024 Q4 1,180,752 $13,258,952 +$407,208 $11.23 41
2024 Q3 1,140,359 $16,387,570 +$1,070,451 $14.37 37
2024 Q2 1,020,904 $17,622,364 +$5,916,793 $17.26 33
2024 Q1 644,693 $12,855,318 +$2,740,211 $19.94 28
2023 Q4 535,932 $5,638,113 +$78,911 $10.52 26
2023 Q3 537,344 $4,749,933 -$815,597 $8.84 23
2023 Q2 628,750 $6,063,402 -$2,464,682 $9.64 23
2023 Q1 827,405 $11,410,584 +$2,160,542 $13.79 26
2022 Q4 671,281 $10,201,395 -$1,651,873 $15.20 19
2022 Q3 792,698 $7,214,000 -$2,079,093 $9.10 17
2022 Q2 1,031,908 $8,742,000 -$136,698 $8.47 25
2022 Q1 909,468 $17,860,000 +$2,451,467 $19.61 32
2021 Q4 759,822 $18,515,000 -$4,465,289 $24.33 34
2021 Q3 815,710 $31,921,000 +$221,525 $39.07 36
2021 Q2 810,815 $36,440,000 +$25,376,026 $44.94 30
2021 Q1 259,549 $8,889,000 +$5,018,995 $34.12 18
2020 Q4 111,645 $4,068,000 +$3,800,925 $36.45 14
2020 Q3 277 $1,000 +$1,000 $3.61 1